State Of Wyoming Kymera Therapeutics, Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $147,250 - $194,458	4,933 New	4,933 $147,000
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $13,451 - $40,507	-952 Reduced 82.42%	203 $4,000
Q1 2022 May 13, 2022	BUY	$35.3 - $64.68 $12,354 - $22,638	350 Added 43.48%	1,155 $49,000
Q4 2021 Feb 11, 2022	BUY	$49.91 - $65.56 $9,982 - $13,112	200 Added 33.06%	805 $51,000
Q3 2021 Feb 11, 2022	SELL	$47.8 - $66.66 $17,064 - $23,797	-357 Reduced 37.11%	605 $36,000
Q2 2021 Feb 11, 2022	BUY	$31.08 - $51.95 $17,249 - $28,832	555 Added 136.36%	962 $47,000
Q1 2021 Feb 08, 2022	BUY	$35.64 - $85.46 $14,505 - $34,782	407 New	407 $16,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.28B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.